CRNX Disposition Disclosure
Bedrosian Camille L · SEC Form 4 · Filed Sep 1, 2026
Disposition
Calculated transaction value
$478.03K
Bedrosian Camille L Director
CRNX
Transaction date
Sep 1, 2026
Public filing date
Sep 1, 2026
Filing lag
Filed same day
CRNX daily price context
Close on/before transaction
$84.95
Sep 1, 2026
Close before public filing
$84.95
Aug 31, 2026
Return since public filing
0.0%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 9,730 shares @ $49.13
- SEC ownership
- Direct
- Transaction code
- D
- Form
- 4
- Filing identifier
- 0001628280-26-059900
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$8.57M
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $1.39M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $503.63K |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $1.72M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $1.13M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $1.17M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $1.13M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $503.63K |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $545.13K |
| Crinetics Pharmaceuticals, Inc. CRNX Current | Disposition | Sep 1, 2026 | $478.03K |